Cordis Recruits Guidant To Block Taxus, Develop Combined Delivery System

Johnson & Johnson/Cordis is betting that its drug-eluting stent marketing alliance with Guidant will allow it to match Boston Scientific's sales presence in U.S. cath labs

More from Archive

More from Medtech Insight